
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cadence Healthcare Ventures is a venture capital firm founded in 2022 and based in Ross, California. The firm focuses on the MedTech industry, particularly in medical devices, health AI, and robotics. Cadence Healthcare Ventures aims to support companies that are transforming healthcare through innovative technologies. The firm has established itself as a key player in the MedTech investment space, emphasizing strategic capital during critical phases of company development.
As of now, Cadence Healthcare Ventures has backed over 60 MedTech companies, generating significant proceeds from multiple exits. The firm operates with a small partnership led by founder Chris Kaster, who has a background in healthcare investments. The firm’s strategy is to align company roadmaps with the priorities of potential acquirers, ensuring that portfolio companies are well-positioned for successful exits.
Cadence Healthcare Ventures is recognized for its focused approach to investing in companies at various stages, particularly during key inflection points such as clinical, regulatory, and commercial phases. The firm’s headquarters in California places it in a strategic location to tap into the vibrant MedTech ecosystem.
Cadence Healthcare Ventures invests primarily in MedTech companies, with a strong emphasis on those integrating artificial intelligence and robotics into healthcare solutions. The firm targets investments at various stages, particularly during critical inflection points such as clinical trials, regulatory approvals, and commercial launches. This focus allows Cadence to provide timely support to companies that are on the verge of significant growth.
The firm typically invests in Series A through D rounds, with a particular sweet spot in Series B investments, averaging around $39 million per round. Cadence Healthcare Ventures emphasizes a strategy that aligns the development roadmaps of its portfolio companies with the interests of potential acquirers, which is crucial for companies aiming for successful exits. This alignment is particularly important in the MedTech sector, where strategic acquisitions are common.
Cadence Healthcare Ventures seeks to partner with founders who are not only innovative but also understand the importance of aligning their business strategies with market demands. The firm’s investment thesis revolves around supporting technologies that have the potential to make a significant impact in the healthcare sector.
Cadence Healthcare Ventures has built a diverse portfolio of over 60 MedTech companies. Notable portfolio companies include:
These companies represent a range of solutions within the MedTech sector, showcasing Cadence's commitment to supporting transformative healthcare technologies. The firm has successfully generated significant proceeds from multiple exits, indicating a strong track record in identifying and nurturing high-potential investments.
Chris Kaster - Founder & Managing Partner. Chris has a background in healthcare investments and has been instrumental in establishing Cadence Healthcare Ventures. His expertise lies in identifying high-potential MedTech companies and aligning their strategies with market demands.
To pitch Cadence Healthcare Ventures, founders should visit their website at cadencehcvc.com. The firm prefers detailed pitch decks that include information on the technology, market potential, and alignment with potential acquirers. A clear articulation of the business model and growth strategy is also essential. Response times may vary, but founders should expect to hear back within a few weeks.
As of April 2026, Cadence Healthcare Ventures has made significant strides in the MedTech sector, having backed over 60 companies since its founding in 2022. The firm has completed two new investments in the trailing 12 months, focusing on companies that are nearing commercialization. Cadence Healthcare Ventures continues to generate significant proceeds from multiple exits, reinforcing its position as a key player in the MedTech investment landscape.
What are Cadence Healthcare Ventures' investment criteria?
Cadence Healthcare Ventures focuses on MedTech companies, particularly those at critical stages of development, including clinical, regulatory, and commercial phases. The firm looks for technologies that integrate AI and robotics into healthcare, aiming for significant impact.
How can I pitch to Cadence Healthcare Ventures?
Founders can submit their pitches through the firm's website at cadencehcvc.com. It is advisable to include detailed information about the technology, market potential, and alignment with potential acquirers in the pitch deck.
What makes Cadence Healthcare Ventures different from other investors?
Cadence Healthcare Ventures emphasizes aligning company roadmaps with the priorities of potential acquirers, which is crucial in the MedTech sector. This strategic focus helps portfolio companies navigate critical growth phases effectively.
What is the typical check size for investments?
The firm typically invests in Series A through D rounds, with average check sizes around $18 million for Series A, $39 million for Series B, $30 million for Series C, and $96 million for Series D.
What geographic areas does Cadence Healthcare Ventures focus on?
Cadence Healthcare Ventures primarily invests in companies based in the United States, leveraging the country's strong MedTech ecosystem.
What kind of support does Cadence Healthcare Ventures provide to portfolio companies?
The firm provides strategic guidance and aligns the development of portfolio companies with the interests of potential acquirers, helping them navigate critical growth phases and positioning them for successful exits.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.